Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (11 quarters reported)
$97.7M in Q4 2023 → $42.8M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Joby Aviation Inc | 100.0% | Unchanged | 4,798,334 | $42.8M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
No position changes this quarter.
quarter ended March 31, 2026 · filed May 15, 2026
No position changes this quarter.
quarter ended December 31, 2025 · filed February 18, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SB Senti Biosciences, Inc. | Exited | −253,755 | −$358K | — |
quarter ended September 30, 2025 · filed November 12, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Joby Aviation, Inc. | Trimmed | −4,798,333 | −$77.4M | 99.5% |
quarter ended June 30, 2025 · filed August 13, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed May 07, 2025
No position changes this quarter.
quarter ended December 31, 2024 · filed February 06, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Joby Aviation, Inc. | Trimmed | −4,798,333 | −$39M | 98.9% |
| B Biomx Inc. | Exited | −108,621 | −$111K | — |
quarter ended September 30, 2024 · filed November 07, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SB Senti Biosciences, Inc. | Trimmed | −2,283,803 | −$5.16M | 0.8% |
| B Biomx Inc. | Trimmed | −977,570 | −$997K | 0.2% |
Loading...
